Skip to main content

Table 2 Adverse events

From: High-dose dual therapy for Helicobacter pylori eradication inducing less impact on the gut microbiota

Adverse event rate

HDDT group

BQT group

P-value

Patients with adverse events

1(4.2%)

13(52.0%)

< 0.001

 Mild

1(4.2%)

8(32.0%)

 

 Moderate

0(0.0%)

3(12.0%)

 

 Severe

0(0.0%)

2(8.0%)

 

Variety of adverse events

   

 Bitter taste

1(4.2%)

6(24.0%)

 

 Diarrhea

0(0.0%)

5(20.0%)

 

 Nausea

0(0.0%)

4(16.0%)

 

 Darkened tongue

0(0.0%)

3(12.0%)

 

 Vomiting

0(0.0%)

2(8.0%)

 

 Stomachache

0(0.0%)

1(4.0%)

 

 Weak

0(0.0%)

1(4.0%)

Â